This document is a published patent application, not a final rule or guidance. It describes a novel composition comprising an esterified fatty acid with 4 to 24 carbon atoms, intended for the prevention or treatment of monogenean infections in aquatic organisms. The application was filed by B. G. Negev Technologies and Applications Ltd. and lists several inventors.

While patent applications do not impose direct regulatory obligations on companies, they signal potential future innovations and intellectual property in the pharmaceutical and animal health sectors. Companies operating in these areas, particularly those involved with aquaculture or fish health products, should be aware of this filing as it may indicate emerging technologies or competitive landscape shifts. No immediate compliance actions are required based on this publication.